Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,208 public trials 2,042 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, not recruiting

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

NCT03869892

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Centro de Oncología e Investigación de Buenos Aires COIBA Berazategui, Argentina
  • Hospital de Gastroenterología Dr. Carlos Borino Udaondo Oncology Unit Buenos Aires, Argentina
  • Fundación Favaloro Oncology Unit Buenos Aires, Argentina
  • Instituto Alexander Fleming Buenos Aires, Argentina
View all 190 locations
View Trial Details
Active, not recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, not recruiting

A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors

NCT04396821

Conditions
Advanced Cancer, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Active, not recruiting

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

NCT05734105

Conditions
Digestive System Diseases, Digestive System Neoplasms, GIST, +7 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 70 locations
View Trial Details
Active, not recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

NCT05539430

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details

Related conditions